Dietary interventions for managing functional bowel disorders are numerous and varied.
Aim
To describe service utilisation patterns and dietary care offered to patients with functional bowel disorders in an outpatient dietetics clinic.
Methods
A retrospective clinical audit of adults (n = 30) with a functional bowel disorder. Patient characteristics, dietary interventions and service-related indicators were extracted from patient records.
Summary
Most patients were female (93%) and aged under 35 years (67%). The wait time to see a dietitian was 4 months and patients were in the service for 20 months. All patients received dietary education, half received artificial nutrition, 40% were recommended supplements, and 30% advised on behavioural modifications. Only one patient was discharged due to the resolution of symptoms following dietetic involvement. This may have been due to the small sample size and focus on symptom resolution rather than a range of outcome measures such as quality of life. Novel interventions for this cohort are warranted.
BamideleJOBrownlowGMFlackRM, et al. (2025) The Mediterranean diet for irritable bowel syndrome. Annals of Internal Medicine 178(2): 1709–1717.
2.
BertinLZanconatoMCrepaldiM, et al. (2024) The role of the FODMAP diet in IBS. Nutrients16(3): 370.
3.
CenniSSesennaVBoiardiG, et al. (2022) The Mediterranean diet in paediatric gastrointestinal disorders. Nutrients15(1): 79.
4.
ChenEYMahurkar-JoshiSLiuC, et al. (2024) The association between a Mediterranean diet and symptoms of irritable bowel syndrome. Clinical Gastroenterology and Hepatology22(1): 164–172.e166.
5.
DrossmanDAHaslerWL (2016) Rome IV-functional GI disorders: Disorders of gut-brain interaction. Gastroenterology150(6): 1257–1261.
6.
GibsonDWattersAMehlerPS (2021) The intersect of gastrointestinal symptoms and malnutrition associated with anorexia nervosa and avoidant/restrictive food intake disorder: Functional or pathophysiologic?-A systematic review. The International Journal of Eating Disorders54(6): 1019–1054.
7.
GoyalOBattaSNohriaS, et al. (2021) Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial. Journal of Gastroenterology and Hepatology36(8): 2107–2115.
8.
GuerreiroMMSantosZCarolinoE, et al. (2020) Effectiveness of two dietary approaches on the quality of life and gastrointestinal symptoms of individuals with irritable bowel syndrome. Journal of Clinical Medicine 9: 125. doi:10.3390/jcm9010125
9.
HarrisCINasarBFinnertyCC (2024) Nutritional implications of mast cell diseases. Journal of the Academy of Nutrition and Dietetics124(11): 1387–1396.
10.
MaCConglySENovakKL, et al. (2021) Epidemiologic burden and treatment of chronic symptomatic functional bowel disorders in the United States: A nationwide analysis. Gastroenterology160(1): 88–98.e84.
11.
MacIntoshAHeenanPEWright-McNaughtonM, et al. (2023) The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders. Frontiers in Nutrition 10: 1060928. doi:10.3389/fnut.2023.1060928
12.
Maxion-BergemannSThieleckeFAbelF, et al. (2006) Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics24(1): 21–37.
13.
PalssonOSWhiteheadWTörnblomH, et al. (2020) Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology158(5): 1262–1273.e1263.
14.
PastaAFormisanoECalabreseF, et al. (2024) Food intolerances, food allergies and IBS: Lights and shadows. Nutrients16(2): 265.
15.
PatrickDLDrossmanDAFrederickIO, et al. (1998) Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure. Digestive Diseases and Sciences43(2): 400–411.
16.
RejAAveryAAzizI, et al. (2022) Diet and irritable bowel syndrome: An update from a UK consensus meeting. BMC Medicine20(1): 287.
17.
SandlerRSEverhartJEDonowitzM, et al. (2002) The burden of selected digestive diseases in the United States. Gastroenterology122(5): 1500–1511.
18.
SinghRZoggHGhoshalUC, et al. (2022) Current treatment options and therapeutic insights for gastrointestinal dysmotility and functional gastrointestinal disorders. Frontiers in Pharmacology 13: 808195. doi:10.3389/fphar.2022.808195
19.
SperberADBangdiwalaSIDrossmanDA, et al. (2021) Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology160(1): 99–114.e113.
20.
TalleyNJ (2008) Functional gastrointestinal disorders as a public health problem. Neurogastroenterology & Motility20(s1): 121–129.
21.
TuckCJReedDEMuirJG, et al. (2020) Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience. Neurogastroenterology and Motility32(1): e13730.
22.
WangJ-KYaoS-K (2021) Roles of gut microbiota and metabolites in pathogenesis of functional constipation. Evidence-Based Complementary and Alternative Medicine2021(1): 5560310.
23.
WhelanKMartinLDStaudacherHM, et al. (2018) The low FODMAP diet in the management of irritable bowel syndrome: An evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. Journal of Human Nutrition and Dietetics31(2): 239–255.
24.
WirthSKlodtCWintermeyerP, et al. (2014) Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie226(5): 268–273.
25.
ZingoneFBertinLManieroD, et al. (2023) Myths and facts about food intolerance: A narrative review. Nutrients15(23): 4969.
